Predictions
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.96
10.05.24
10.05.24
-
10.05.25
10.05.25
-4.22%
11.05.24
11.05.24
Could be worthwhile Investment >10% per year
Cytomx Therapeutics Inc
Start price
Target price
Perf. (%)
€3.85
08.05.24
08.05.24
-
08.05.25
08.05.25
-44.13%
09.05.24
09.05.24
Heron Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.21
02.05.24
02.05.24
€10.00
19.02.25
19.02.25
19.26%
05.05.24
05.05.24
Cytomx Therapeutics Inc
Start price
Target price
Perf. (%)
€4.30
01.05.24
01.05.24
-
01.05.25
01.05.25
-55.79%
10.05.24
10.05.24
Viking Therapeutics Inc
Start price
Target price
Perf. (%)
€69.50
29.04.24
29.04.24
€100.00
31.03.26
31.03.26
-0.75%
03.05.24
03.05.24
Could be very worthwhile Investment >20% year
Viking Therapeutics Inc
Start price
Target price
Perf. (%)
€69.80
29.04.24
29.04.24
€100.00
29.04.25
29.04.25
-2.03%
11.05.24
11.05.24
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€3.96
28.04.24
28.04.24
-
28.04.25
28.04.25
24.79%
11.05.24
11.05.24
Bastide Le Confort
Start price
Target price
Perf. (%)
€17.88
27.04.24
27.04.24
-
27.04.25
27.04.25
8.84%
11.05.24
11.05.24
Could be worthwhile Investment >10% per year
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€1.85
25.04.24
25.04.24
-
25.04.25
25.04.25
-1.11%
27.04.24
27.04.24
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.60
25.04.24
25.04.24
-
25.04.25
25.04.25
-2.00%
27.04.24
27.04.24
Could be worthwhile Investment >10% per year
Abeona Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.52
23.04.24
23.04.24
-
23.04.25
23.04.25
-11.36%
28.04.24
28.04.24
Abeona Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.68
23.04.24
23.04.24
-
23.04.25
23.04.25
-15.22%
27.04.24
27.04.24
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.50
19.04.24
19.04.24
-
19.04.25
19.04.25
-12.02%
10.05.24
10.05.24
Could be very worthwhile Investment >20% year
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€1.31
16.04.24
16.04.24
-
16.04.25
16.04.25
6.59%
27.04.24
27.04.24
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€1.63
16.04.24
16.04.24
-
16.04.25
16.04.25
-14.11%
28.04.24
28.04.24
Viking Therapeutics Inc
Start price
Target price
Perf. (%)
€62.08
16.04.24
16.04.24
-
22.03.25
22.03.25
14.66%
30.04.24
30.04.24
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€1.00
15.04.24
15.04.24
-
15.04.25
15.04.25
11.00%
30.04.24
30.04.24
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€1.24
15.04.24
15.04.24
-
12.04.25
12.04.25
12.90%
18.04.24
18.04.24
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€1.51
14.04.24
14.04.24
-
14.04.25
14.04.25
-0.66%
28.04.24
28.04.24
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€1.07
13.04.24
13.04.24
€1.00
13.04.25
13.04.25
-2.80%
27.04.24
27.04.24
Probably not worthwhile Investment
Lower EBIT Margin than peer group
Bad rating
ROE lower than 10% per year
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€1.51
13.04.24
13.04.24
€2.00
13.04.25
13.04.25
-0.66%
27.04.24
27.04.24
negative Cash Flow expected
Few uniques
Growths slower than the competition
Below average Marketposition
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€1.48
12.04.24
12.04.24
-
12.04.25
12.04.25
-16.22%
15.04.24
15.04.24
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€1.72
11.04.24
11.04.24
-
11.04.25
11.04.25
-12.21%
14.04.24
14.04.24
Could be worthwhile Investment >10% per year